Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 2/2005

01-02-2005 | Case report

Juvenile hepatocellular carcinoma with congestive liver cirrhosis

Authors: Yuko Izumi, Naoki Hiramatsu, Ichiyo Itose, Takahiro Inoue, Akira Sasagawa, Satoshi Egawa, Tsutomu Nishida, Yoshimi Kakiuchi, Takashi Toyama, Fumihiko Nakanishi, Kazuyoshi Ohkawa, Kiyoshi Mochizuki, Tatsuya Kanto, Masahiko Tsujii, Tetsuo Takehara, Shingo Tsuji, Michio Kato, Akinori Kasahara, Norio Hayashi

Published in: Journal of Gastroenterology | Issue 2/2005

Login to get access
Metadata
Title
Juvenile hepatocellular carcinoma with congestive liver cirrhosis
Authors
Yuko Izumi
Naoki Hiramatsu
Ichiyo Itose
Takahiro Inoue
Akira Sasagawa
Satoshi Egawa
Tsutomu Nishida
Yoshimi Kakiuchi
Takashi Toyama
Fumihiko Nakanishi
Kazuyoshi Ohkawa
Kiyoshi Mochizuki
Tatsuya Kanto
Masahiko Tsujii
Tetsuo Takehara
Shingo Tsuji
Michio Kato
Akinori Kasahara
Norio Hayashi
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 2/2005
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-004-1525-4

Other articles of this Issue 2/2005

Journal of Gastroenterology 2/2005 Go to the issue

OriginalPaper

Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis

Editorial

Interobserver variation in assessing small bile duct lesions in PBC, CVH, and AIH

OriginalPaper

Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer

Review

Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders

OriginalPaper

Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts

Letters to the editor

Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits